New vaccine to tackle Japanese Encephalitis

Published: 14th September 2012 10:16 AM  |   Last Updated: 14th September 2012 10:18 AM   |  A+A-

Biological E Ltd (BE), on Thursday, launched the country’s first indigenously developed vaccine for Japanese Encephalitis (JE), which will be marketed under the brand name — JEEV.

The company has so far invested about `400 crore, of which over 20 per cent has been pumped into the development of JE vaccine. The company said it is in the process of obtaining WHO pre-qualification approval for JEEV, which will enable the vaccine to be exported to global agencies.

“Developed over 7 years of in-house R&D and support from its technology partner, Austria-based Intercell AG, JEEV is a second generation inactivated Japanese Encephalitis vaccine based on the SA 14-14-2 strain and does not contain any Gelatin stabilizers or Thiomersal and the vaccine’s safety,” said Mahima Datla, Senior Vice President (Operations), BE.

According to estimates, there were over 8,000 confirmed cases recorded in India in 2011, with over 1,100 deaths. There’s no specific treatment available for JE. There is no other vaccine available to private doctors in India currently.

“With the launch of JEEV, the indigenous vaccine with excellent safety profile and proven efficacy in Indian subjects is now available to doctors for prevention of Japanese Encephalitis in children and adults,” said Dr Vijay Kumar Datla, CMD, BE.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp